Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Pharmacokinetic study of K-877 (pemafibrate) in patients with primary biliary cholangitis
jRCT2080223672Phase 1Completed
- Sponsor
- Kowa Company, Ltd.
- Start
- Oct 2017
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 1, open-label, single-arm trial of pemafibrate in primary biliary cholangitis (PBC), sponsored by Kowa Company, Ltd. Primary endpoint: Pharmacokinetics of pemafibrate. Started Oct 2017; status: completed.
02
Drugs
pemafibrate
03
Conditions
primary biliary cholangitis (PBC)
Beyond the preview
Go deeper on jRCT2080223672.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on jRCT2080223672.